Tempus AI, Inc. (TEM)
equity · Nasdaq
- Last 30 days
- 19 mentions · 1 episodes
- Last 90 days
- 19 mentions · 1 episodes
Stance shows how speakers talked about the asset, not investment advice. Figures and views are speaker claims; verify them against the original audio and primary sources.
Mentions over time
Recent mentions
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_1) bullish
“No, because there are plenty of legacy lab companies that can sequence DNA perfectly well. But Tempest pairs that raw genomic data with longitudinal electronic health records.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_0) bullish
“Which completely explains why the tech giants and pharma companies are just lining up at Tempest's door.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_0) bullish
“Tempest isn't just sitting back and passively licensing this data like some static library.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_1) bullish
“Exactly the point. Because Tempest has the historical records of millions of patients, the AI can instantly generate a synthetic control arm.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_0) bullish
“So if we think of precision oncology as a modern-day gold rush, Tempest isn't just out there in the mud mining the gold through their diagnostic labs.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_1) bearish
“Exactly. Tempest owns the biological data, but they are renting the computational power to make sense of it.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_0) bearish
“Owning the map to the gold mine sounds like a flawless business model, but forensic short sellers, most notably Spruce Point Capital, have released reports flagging that some of the major companies paying these lucrative tolls to Tempest might actually be heavily related to Tempest itself.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_1) bearish
“Okay. Pathos is an AI drug development firm. And the key detail here is that it was co-founded by Tempest's Tempus' own CEO.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_1) bearish
“Yes. And according to the disclosures, Tempest entered into a $55 million dataset licensing agreement with Pathos.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_1) bearish
“Correct. And currently, Pathos accounts for approximately $200 million of dollars Tempest's total contract value or TCV.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_0) neutral
“Okay. Then we have the SoftBank joint venture, which operates under the name SB Tempest.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_1) neutral
“It was capitalized with roughly ninety-five million dollars provided by Tempest.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_1) bearish
“of course the supply chain exposure to Illumina amidst global tariffs. Any of those could fundamentally break the Tempest business model.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_1) neutral
“Currently Tempest trades at roughly 9.0 times enterprise value to FY26 estimated sales.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_1) bearish
“Tempest currently fails this test. They have roughly a 25% revenue growth rate.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_0) bearish
“Right. If we run Tempest through Warren Buffett's classic conservative investment criteria, what is the actual result?”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_1) neutral
“Out of all the classic Buffett criteria, the only test that Tempest actually passes is possessing a formidable, highly defensible economic moat in its proprietary data.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_1) neutral
“Exactly. Tempest AI is a speculative, hyper-growth venture asset that happens to be trading on the public markets.”
Explain It to Me Please ·
2026Q3 Tempus AI Inc. (TEM)
Unidentified speaker (speaker_0) neutral
“As Tempest builds the world's most powerful agentic AI. models for healthcare, who actually owns the ultimate value of the biological insights that are inevitably discovered?”
Claims about this asset
Unidentified speaker (speaker_1) says: Representative Nancy Pelosi purchased 50 TEM call options with a $20 strike price on January 14, 2025, and exercised them on January 16, 2026.
How to verify: Congressional Financial Disclosure Reports (CFDR) filed by Rep. Pelosi via Capitol.gov or OpenSecrets.org; SEC Form 4 filings for insider transactions. For recent events, verify 2026-08-06 through 2026-11-06. Use another period only when the speaker explicitly names it.
2026Q3 Tempus AI Inc. (TEM)Primary source
Often mentioned with
No other assets in the same segments yet.
Podcasts that cover it most
- Explain It to Me Please · 19 mentions